Kulkarni Samarth
5 of 8 shown
The 5 most recent of 8 visible filings, newest first.
- CRISPR Therapeutics AG Chief executive officer28,750 sharesGrant
- CRISPR Therapeutics AG Chief executive officer57,500 sharesGrant
- CRISPR Therapeutics AG Chief executive officer$2,381,326Open-market sale
- CRISPR Therapeutics AG Chief executive officer—Option exercise
- CRISPR Therapeutics AG Chief executive officer—Option exercise